Aprea Therapeutics, Inc. (APRE)
EBITDA Margin
-10103.30%
TTM · Period ending:
APRE EBITDA Margin
Latest reported-10103.30%period ending
Latest reported-10103.30%period ending
APRE TTM EBITDA Margin (-5624.12% → -10103.30%)
TTM ebitda margin
High-resolution chart · PNG
APRE ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -10,103.3037% | |
| -4,482.9008% | |
| -2,676.2469% | |
| -1,644.2551% | |
| -1,094.5864% | |
| -860.9448% | |
| -1,028.7526% | |
| -1,012.0071% | |
| -1,318.1322% | |
| -2,448.3788% | |
| -2,333.7147% | |
| -5,624.1161% |